ORA™ releases it new patented technology – WNE® system – the founding stone of a revolutionary range of innovative and ultra-reliable PET synthesizers

Philippeville, Belgium, June 8th June 2013 / Optimized Radiochemical Applications (ORA™) today announced the release of its new patented technology: WNE® system. This technology allows the design of 3-position pneumatic actuator that will be equipping the new 2013 range of NEPTIS® synthesizers: NEPTIS® perform, NEPTIS® mosaic-RS and NEPTIS® mosaic-LC.

Recent trends in the development of new PET diagnostic tracers require more complex chemistries.  They in turn necessitate almost unlimited flexibility for the fluid pathway design.  The 3-position pneumatic actuator system is the effective solution for this, removing all constraints on the fluid pathway design.  Further, this system is more compact by 25% compared to traditional actuator technology.

In a radioactive environment, long term reliability of components is essential.  While electrically-driven actuator systems are susceptible to radiation, pneumatic systems provide unmatched reliability.  The WNE® system guarantees accurate positioning of the 3-position actuators, essentially.  Unlike electrically-driven actuators, there is no need for any electronic logic control system.  Only pneumatic pressure is required for their operation.

WNE® system is the founding stone of the revolutionary range of innovative and ultra-reliable NEPTIS® PET synthesizers. This new 2013 range consists of the following models, all equipped with 3-position pneumatic actuators:

  • NEPTIS® perform, a integrated synthesizer with HPLC and SPE reform for advanced and complex tracers
  • NEPTIS® mosaic-RS, a compact synthesizer compatible with all available ABX kits for generic tracers
  • NEPTIS® mosaic-LC, an ultra-compact synthesizer to optimize running production costs

ORA™ is exhibiting at booth number #1500 at the Society for Nuclear Medicine (SNM) Annual Meeting 2013 from 8-12 June in Vancouver, Canada.


NEPTIS® synthesizers, dedicated for the production of PET radiopharmaceuticals, aimed since their inception to address the various challenges, different by nature, of personalized medicine, a young but rapidly advancing field of healthcare: restoring freedom for researchers with an open and flexible freedom, providing developers with a robust tool from clinical trials to commercial production, and offering producers a guarantee of reliable and repetitive performance. Additional information about NEPTIS® is available at www.neptis-vsa.com.

About Optimized Radiochemical Applications (ORA™)

ORA, an innovation-driven Belgian company based founded in 2006, is developing an extensive range of PET synthesizers for existing and new radiopharmaceuticals and collaborates with major research institutions and pharmaceutical companies worldwide. Additional information about ORA is available at www.oradiochem.eu.


Fig.1. – Standard ramp of five sets of 3-position pneumatic actuators using patented technology WNE® system as used on the new range of NEPTIS® synthesizers.


For immediate release

Contact: Vincent Tadino
Phone: (0032) 71 61 40 53
Email: info@oradiochem.eu


©ORA Belgium, 2013. All rights reserved. PR13005
NEPTIS® is a trademark of ORA™

Print Friendly, PDF & Email